Table of ContentsOctober 1997 EDITORIAL
A Kiss Is Just a KissHow to allay your patients' concerns about that C.D.C. case of purported oral-oral transmissionPAUL A. VOLBERDING, M.D.
OPTIMAL MEDICAL MANAGEMENT The Challenge of Multidrug-Resistant TuberculosisThe clinical features, diagnosis, and treatment of TB in patients with HIV infectionROBERT M. JASMER, M.D., and LAURENCE HUANG, M.D.
NEWSLINE Newsline...Newsline...Newsline...Predictors of TB infection: Geographical region and induration size of positive PPD test help identify those at risk... Isoniazid in HIV-positive patients at high risk for TB: Six months of prophylaxis produces no benefit... C.D.C. data can help clinicians identify patients at high risk for drug-resistant TB... Combivir®, first two-in-one antiretroviral agent, wins F.D.A. approval..."Prevention Works!," an update: Skills-building prevention programs for men who have sex with men prove effective -- and cost-effective as well... Broad-based prevention programs have little impact on high-risk behavior, but targeted interventions produce results... Transmission risk can be reduced among IDUs, but only when indirect risks are also addressed...PULL OUT AND SAVE Foods That Can Be Eaten in Conjunction with CrixivanA list of low-fat and no-fat snacks that your patients can take along with their indinavir dose, if they need to eat at a scheduled dosing time
CASE MANAGEMENT Joan J., a Treatment-Naïve Patient Who Isn't Naïve About Treatment OptionsIs this individual a candidate for aggressive suppression therapy?HARVEY J. MAKADON, M.D. This article was provided by San Francisco General Hospital. It is a part of the publication HIV Newsline. |
|